Nifty
Sensex
:
:
23727.65
78472.87
-25.80 (-0.11%)
-67.30 (-0.09%)

Chemicals

Rating :
N/A

BSE: 543213 | NSE: ROSSARI

784.95
24-Dec-2024
  • Open
  • High
  • Low
  • Previous Close
  •  785.15
  •  793.00
  •  779.65
  •  781.25
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  15525
  •  121.99
  •  972.70
  •  656.95

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 4,346.30
  • 31.32
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 4,461.85
  • 0.06%
  • 3.89

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 68.27%
  • 0.35%
  • 9.56%
  • FII
  • DII
  • Others
  • 3.74%
  • 17.23%
  • 0.85%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 26.75
  • 24.99
  • 7.27

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 32.49
  • 18.34
  • 6.64

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 42.71
  • 14.83
  • 10.19

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 38.98

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 5.08

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 20.90

Earnings Forecasts:

Description
2024
2025
2026
2027
Adj EPS
23.67
28.63
34.66
41.37
P/E Ratio
35.15
29.07
24.01
20.12
Revenue
1831
2124
2474
2824
EBITDA
250
289
344
389
Net Income
131
152
191
228
ROA
8.9
8.6
9.8
10.8
P/Bk Ratio
4.39
3.8
3.28
ROE
13.32
13.83
15.57
16.25
FCFF
-101.31
52.78
121.59
144.31
FCFF Yield
-2.19
1.14
2.63
3.12

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 24
Sep 23
Var%
Jun 24
Jun 23
Var%
Mar 24
Mar 23
Var%
Dec 23
Dec 22
Var%
Net Sales
498.35
483.47
3.08%
489.65
410.61
19.25%
472.71
406.47
16.30%
463.77
389.27
19.14%
Expenses
432.41
419.90
2.98%
424.76
352.86
20.38%
409.12
351.88
16.27%
400.10
335.11
19.39%
EBITDA
65.94
63.57
3.73%
64.89
57.75
12.36%
63.59
54.58
16.51%
63.67
54.16
17.56%
EBIDTM
13.23%
13.15%
13.25%
14.06%
13.45%
13.43%
13.73%
13.91%
Other Income
0.72
1.36
-47.06%
0.95
2.19
-56.62%
0.39
2.81
-86.12%
3.50
1.11
215.32%
Interest
3.68
5.03
-26.84%
3.69
6.32
-41.61%
2.52
4.35
-42.07%
4.32
4.67
-7.49%
Depreciation
15.16
15.11
0.33%
15.37
14.11
8.93%
16.07
16.02
0.31%
15.09
15.96
-5.45%
PBT
47.82
44.79
6.76%
46.78
39.51
18.40%
45.39
37.03
22.58%
47.76
34.65
37.84%
Tax
12.78
11.86
7.76%
12.09
10.24
18.07%
11.44
8.25
38.67%
13.39
8.99
48.94%
PAT
35.04
32.93
6.41%
34.69
29.27
18.52%
33.95
28.77
18.00%
34.37
25.66
33.94%
PATM
7.03%
6.81%
7.08%
7.13%
7.18%
7.08%
7.41%
6.59%
EPS
6.39
5.97
7.04%
6.32
5.30
19.25%
6.18
5.25
17.71%
6.23
4.66
33.69%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 16
Mar 15
Mar 14
Net Sales
1,924.48
1,830.56
1,655.88
1,482.97
709.35
600.09
516.22
291.80
178.66
171.07
155.00
Net Sales Growth
13.89%
10.55%
11.66%
109.06%
18.21%
16.25%
76.91%
63.33%
4.44%
10.37%
 
Cost Of Goods Sold
1,342.85
1,293.52
1,171.32
1,107.79
462.20
371.70
339.27
196.56
130.58
123.41
107.97
Gross Profit
581.63
537.03
484.57
375.18
247.15
228.39
176.95
95.24
48.07
47.65
47.04
GP Margin
30.22%
29.34%
29.26%
25.30%
34.84%
38.06%
34.28%
32.64%
26.91%
27.85%
30.35%
Total Expenditure
1,666.39
1,587.48
1,441.32
1,306.68
586.29
495.35
438.67
247.14
166.14
156.49
140.34
Power & Fuel Cost
-
23.30
20.40
11.91
2.40
1.74
1.26
0.85
0.80
0.64
0.55
% Of Sales
-
1.27%
1.23%
0.80%
0.34%
0.29%
0.24%
0.29%
0.45%
0.37%
0.35%
Employee Cost
-
103.13
98.62
67.93
41.98
37.21
27.52
19.61
11.53
11.36
10.72
% Of Sales
-
5.63%
5.96%
4.58%
5.92%
6.20%
5.33%
6.72%
6.45%
6.64%
6.92%
Manufacturing Exp.
-
40.62
28.23
25.67
18.88
26.64
27.82
2.35
3.28
3.32
3.00
% Of Sales
-
2.22%
1.70%
1.73%
2.66%
4.44%
5.39%
0.81%
1.84%
1.94%
1.94%
General & Admin Exp.
-
43.51
36.13
25.14
14.74
16.83
13.64
10.78
1.38
5.89
6.32
% Of Sales
-
2.38%
2.18%
1.70%
2.08%
2.80%
2.64%
3.69%
0.77%
3.44%
4.08%
Selling & Distn. Exp.
-
64.36
67.50
48.37
34.74
33.96
24.43
9.58
3.05
7.52
8.09
% Of Sales
-
3.52%
4.08%
3.26%
4.90%
5.66%
4.73%
3.28%
1.71%
4.40%
5.22%
Miscellaneous Exp.
-
19.03
19.14
19.86
11.36
7.27
4.73
7.41
15.51
4.35
8.09
% Of Sales
-
1.04%
1.16%
1.34%
1.60%
1.21%
0.92%
2.54%
8.68%
2.54%
2.39%
EBITDA
258.09
243.08
214.56
176.29
123.06
104.74
77.55
44.66
12.52
14.58
14.66
EBITDA Margin
13.41%
13.28%
12.96%
11.89%
17.35%
17.45%
15.02%
15.31%
7.01%
8.52%
9.46%
Other Income
5.56
14.12
13.95
19.14
9.19
3.72
0.91
1.41
0.38
0.30
0.33
Interest
14.21
19.37
22.32
12.66
2.99
3.56
2.88
1.36
3.53
5.05
5.43
Depreciation
61.69
60.39
62.93
48.05
22.83
16.85
12.19
5.16
4.52
5.09
5.09
PBT
187.75
177.44
143.26
134.73
106.43
88.06
63.39
39.55
4.85
4.75
4.46
Tax
49.70
46.93
36.96
38.58
26.79
22.59
17.71
10.53
1.47
1.02
0.66
Tax Rate
26.47%
26.45%
25.80%
28.64%
25.17%
25.65%
27.94%
26.62%
30.31%
21.47%
14.80%
PAT
138.05
130.69
107.26
97.67
79.81
65.47
45.68
29.01
3.39
3.73
3.80
PAT before Minority Interest
138.05
130.69
107.26
97.69
79.64
65.47
45.68
29.01
3.39
3.73
3.80
Minority Interest
0.00
0.00
0.00
-0.02
0.17
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
7.17%
7.14%
6.48%
6.59%
11.25%
10.91%
8.85%
9.94%
1.90%
2.18%
2.45%
PAT Growth
18.37%
21.84%
9.82%
22.38%
21.90%
43.32%
57.46%
755.75%
-9.12%
-1.84%
 
EPS
24.96
23.63
19.40
17.66
14.43
11.84
8.26
5.25
0.61
0.67
0.69

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Shareholder's Funds
1,047.73
915.17
805.16
408.77
286.68
123.81
94.37
Share Capital
11.05
11.03
11.01
10.39
10.15
4.40
4.40
Total Reserves
1,033.14
900.63
790.87
396.27
276.04
119.41
89.97
Non-Current Liabilities
192.97
180.86
251.37
59.10
69.02
37.15
3.61
Secured Loans
33.32
34.93
0.00
0.00
33.96
0.67
1.29
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
102.07
82.35
98.75
58.12
34.57
34.71
0.00
Current Liabilities
583.93
475.66
360.24
176.88
168.85
121.80
67.64
Trade Payables
219.10
181.02
186.15
131.11
97.00
105.98
40.39
Other Current Liabilities
128.49
125.96
99.73
17.41
20.33
11.91
5.54
Short Term Borrowings
62.53
29.01
0.00
0.00
27.05
3.27
18.83
Short Term Provisions
173.82
139.67
74.36
28.35
24.47
0.63
2.88
Total Liabilities
1,824.63
1,571.69
1,416.77
644.75
524.55
282.76
165.62
Net Block
577.56
585.23
607.14
181.25
93.54
74.00
45.03
Gross Block
790.88
743.02
704.33
233.82
122.47
86.19
87.62
Accumulated Depreciation
213.33
157.79
97.18
52.57
28.93
12.19
42.59
Non Current Assets
820.65
723.11
741.91
263.33
178.08
122.92
60.08
Capital Work in Progress
47.21
16.08
1.34
0.32
21.75
2.83
9.99
Non Current Investment
25.28
25.18
24.37
0.00
4.17
0.00
3.00
Long Term Loans & Adv.
170.53
96.50
108.69
62.12
58.20
38.70
2.07
Other Non Current Assets
0.07
0.12
0.36
19.65
0.42
7.39
0.00
Current Assets
1,002.77
847.37
674.87
381.42
346.46
159.84
105.53
Current Investments
37.58
26.00
11.55
0.00
13.73
0.00
4.16
Inventories
282.33
188.48
189.93
95.35
58.17
54.90
35.10
Sundry Debtors
425.13
353.66
304.85
144.07
94.14
85.92
59.80
Cash & Bank
30.21
123.94
52.35
88.26
127.23
6.01
0.76
Other Current Assets
227.52
3.33
5.59
1.60
53.20
13.01
5.72
Short Term Loans & Adv.
225.37
151.96
110.60
52.13
52.28
12.52
5.40
Net Current Assets
418.84
371.70
314.63
204.53
177.61
38.04
37.89
Total Assets
1,823.42
1,570.48
1,416.78
644.75
524.54
282.76
165.61

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Cash From Operating Activity
43.26
151.56
29.36
47.77
56.83
71.18
23.59
PBT
177.62
144.22
136.28
106.84
88.06
63.39
39.55
Adjustment
76.36
82.95
55.25
20.58
19.99
16.76
5.64
Changes in Working Capital
-156.85
-27.83
-112.05
-48.30
-31.07
11.39
-11.07
Cash after chg. in Working capital
97.13
199.34
79.48
79.11
76.98
91.55
34.12
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-53.88
-47.78
-50.12
-31.35
-20.15
-20.37
-10.53
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-103.21
-180.89
-298.88
-37.18
-190.30
-36.42
-20.49
Net Fixed Assets
-38.19
-17.69
-31.54
-76.44
-55.20
5.15
Net Investments
-35.07
-112.23
-371.61
5.96
-14.98
2.97
Others
-29.95
-50.97
104.27
33.30
-120.12
-44.54
Cash from Financing Activity
16.18
60.85
291.79
-24.59
156.94
-29.15
-4.67
Net Cash Inflow / Outflow
-43.77
31.52
22.27
-14.00
23.47
5.61
-1.57
Opening Cash & Equivalents
69.20
37.48
15.21
29.21
5.74
0.63
2.33
Closing Cash & Equivalent
25.17
69.20
37.48
15.21
29.21
5.74
0.76

Financial Ratios

Consolidated /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 16
Mar 15
Mar 14
Book Value (Rs.)
189.01
165.29
145.65
78.31
56.39
281.39
214.47
113.64
106.56
100.59
ROA
7.70%
7.18%
9.48%
13.62%
16.22%
20.38%
20.00%
3.04%
3.11%
3.03%
ROE
13.36%
12.52%
16.17%
22.99%
31.94%
41.88%
36.33%
6.99%
8.18%
8.60%
ROCE
18.39%
18.48%
24.37%
28.70%
38.02%
54.40%
40.37%
10.30%
10.70%
10.69%
Fixed Asset Turnover
2.40
2.30
3.18
4.01
5.78
5.94
3.65
3.41
2.54
2.30
Receivable days
77.31
72.29
55.00
60.78
54.48
51.48
65.53
61.97
61.77
66.45
Inventory Days
46.74
41.54
34.95
39.17
34.21
31.80
35.88
57.73
78.22
98.62
Payable days
56.45
57.21
52.27
90.07
76.09
59.57
55.94
57.81
59.03
72.35
Cash Conversion Cycle
67.59
56.62
37.69
9.88
12.61
23.70
45.47
61.89
80.96
92.72
Total Debt/Equity
0.10
0.08
0.01
0.00
0.23
0.04
0.22
0.45
0.93
1.00
Interest Cover
10.17
7.46
11.77
36.57
25.76
23.03
30.15
2.38
1.94
1.82

News Update:


  • Rossari Biotech - Quarterly Results
    19th Oct 2024, 15:21 PM

    Read More
  • Rossari Biotech’s arm incorporates step down wholly owned subsidiary
    9th Oct 2024, 12:30 PM

    Rossari Global DMCC has incorporated a step down wholly owned subsidiary in the name of ‘Rossari Biotech Trading FZE’

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.